Carregant...
Pigmentary changes in patients treated with targeted anticancer agents: a systematic review and meta-analysis
BACKGROUND: The discovery of signaling networks that drive oncogenic processes has led to the development of targeted anticancer agents. The burden of pigmentary adverse events from these drugs is unknown. OBJECTIVE: To conduct a systematic review and meta-analysis of published clinical trials, and...
Guardat en:
| Publicat a: | J Am Acad Dermatol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5657394/ https://ncbi.nlm.nih.gov/pubmed/28918974 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaad.2017.06.044 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|